SNBP, 23 of Its Generic Drugs, in China’s National Essential Drugs List. SNBP, X-Treme Hot Stock Alert by DrStockPick.com
Dr Stock Pick HOT News & Alerts!
_______________________________________
FREE Daily Stock Alerts From DrStockPick.com
_______________________________________
Monday November 16, 2009
DrStockPick.com Stock Report!
**************************************************************
SNBP, Sinobiopharma Inc., SNBP.OB
SNBP is a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world’s fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. in China, SNBP’s current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.
SNBP reported that 23 generic drugs for which the Company has production rights are listed in China’s National Essential Drugs List, which covers pharmaceuticals used to treat up to 80 percent of the most common diseases in China.
According to the Chinese government’s healthcare reform plan, 90 percent of China’s citizens will be covered by a universal healthcare system by the year 2010.
The inclusion of 23 generic drugs for which SNBP owns production rights on the National Essential Drugs List, would enable SNBP to increase both sales and margins.
SNBP, X-Treme Hot Stock Alert by DrStockPick.com
***********Advertisement***********
******************************
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) . Rule 17B requires disclosure of payment for investor relations.
Tags: Sinobiopharma Inc, SNBP, SNBP.OB
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
